Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Alphabet Inc Class A (GOOGL) Price & Performance

CVS Health CorpTrade
Alphabet Inc Class ATrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Alphabet Inc Class A — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while Alphabet Inc Class A trades at $350.39 (market cap $4.24T). The key difference: Alphabet Inc Class A is far larger — about 37.8× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Alphabet Inc Class A for 85 Days on average.

CVSGOOGL
Market Cap
$112.29B$4.24T
Volume
7,763,67623,392,850
Sector
HealthMedia
52-Week High
$110.60$402.62
52-Week Low
$70.08$236.59
Typical Hold Time
83 Days85 Days
Enterprise Value
$174.64B$4.13T
Dividend Yield
3.03%0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.

The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.

Alphabet Inc Class A

Alphabet (GOOGL) trades at $350.50, up 0.81% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals, including a 32.8% net income margin in 2025 and projected revenue growth to $445.9B in 2026. Analyst consensus is overwhelmingly positive, with an 86.75% buy rating and a $431.83 price target. Recent news highlights AI-driven growth opportunities and strategic partnerships.

The outlook for GOOGL remains favorable due to strong financial performance, AI integration, and analyst optimism. Key risks include regulatory scrutiny and market volatility. With solid cash flow and expanding profitability, the stock presents a compelling opportunity for growth-oriented investors, though attention to competitive and macroeconomic factors is advised.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

GOOGL
34% Buy66% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

Read more on GOOGL →